Merck expects to be denied approval for sugammadex injection again

March 13 (Reuters) - Merck & Co Inc said it expected to be denied U.S. approval for its sugammadex injection, after the U.S. Food and Drug Administration said it would conduct additional site inspections related to a study of the drug.